Clinical-AI company Aidoc has received U.S. Food and Drug Administration (FDA) Breakthrough Device Designation for First Read, an artificial-intelligence tool that analyzes chest radiographs and generates preliminary, high-quality draft radiology report text. Announced on 25 June 2026, it is Aidoc's second Breakthrough designation in under a year.
Tackling a reporting bottleneck
The designation targets a growing strain on radiology. A Neiman Health Policy Institute study found that outpatient imaging interpretation turnaround times more than doubled between 2014 and 2023, with the steepest increases in the most recent years. By drafting report text directly from imaging findings, First Read aims to cut time spent on reporting and interpretation, returning capacity to radiologists for higher-value clinical judgment. The designation covers four life-threatening findings; the device remains investigational and is not yet cleared for marketing.
Built on a validated foundation
First Read extends Aidoc's clinically validated CARE foundation model and shares the underlying architecture of Triage, the company's FDA-cleared abdominal CT triage application, which complements Aidoc's earlier multi-finding CT triage clearance. The broader platform supports care decisions across nearly 2,000 hospitals worldwide, including Sutter Health, WellSpan Health and Mercy, and has analyzed more than 120 million patient cases. The company's aiOS operating system, backed by investors including NVIDIA's NVentures arm, delivers AI directly inside existing imaging and EMR workflows.
Safety and oversight first
Aidoc framed the launch around governance, noting that errors, inconsistencies and automation bias are known risks of generative AI in reporting, "where every sentence carries clinical and legal weight." First Read is designed to keep clinicians in control, with radiologists retaining final approval. "Radiology is entering a new era," said CEO Elad Walach, describing the tool as a step toward AI that absorbs operational burden while preserving clinician oversight. The push echoes parallel moves to embed AI in reporting, such as Cortechs.ai's integration with Microsoft PowerScribe.
Reporting based on coverage from Imaging Technology News and PR Newswire.